Based in the U.S., Matthew Erick is Biocon Biologics’s Chief Commercial Officer, Advanced Markets. Matt joined Biocon in 2022 and is responsible for driving the commercial strategy and sales for Biocon Biologics in the advanced markets of North America, Europe, Japan, Australia and New Zealand. With more than two decades of experience in pharma and healthcare, Matt has held commercial and executive leadership roles at MedVet, Viatris, and Cardinal Health in the U.S. Matt holds Bachelor’s degrees in both Pharmacy and Biology.